Imgatuzumab
Imgatuzumab (RG 7160) is a humanized monoclonal antibody against the EGFR. Imgatuzumab acts as an immunomodulator. Imgatuzumab can be used in research of cancer[1].
Product Specifications
CAS Number
[959963-46-3]
Product Name Alternative
RG 7160; RO 5083945; Anti-EGFR Recombinant Antibody
UNSPSC
12352203
Target
EGFR
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/imgatuzumab.html
Purity
99.41
Solubility
10 mM in DMSO
Smiles
[Imgatuzumab]
Molecular Weight
(145.28 kDa)
References & Citations
[1]Gonzalez-Nicolini V, et, al. Premedication and Chemotherapy Agents do not Impair Imgatuzumab (GA201) -Mediated Antibody-Dependent Cellular Cytotoxicity and Combination Therapies Enhance Efficacy. Clin Cancer Res. 2016 May 15;22 (10) :2453-61.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15109777 1 Vial
Lentiviral mouse Agpat5 shRNA (UAS) - Lentiviral mouse Agpat5 shRNA (UAS, RFP) plasmid
Ask
View Details 
210073-01 50 µL
CDKN1A (Cyclin-dependent Kinase Inhibitor 1, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1, p21) discontinued
Ask
View Details 210073-02 100 µL
CDKN1A (Cyclin-dependent Kinase Inhibitor 1, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1, p21) discontinued
Ask
View Details 210073-03 200 µL
CDKN1A (Cyclin-dependent Kinase Inhibitor 1, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1, p21) discontinued
Ask
View Details